Clinical Trial Update: Subconjunctival Sirolimus for the Treatment of Autoimmune Active Anterior Uveiti [Phase 1]

View source ↗

Summary

This clinical trial update notes the completion of a Phase 1 study evaluating subconjunctival sirolimus for autoimmune active anterior uveitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anterior Uveitis

Drugs mentioned

• Rapamune (sirolimus) (sirolimus)

Snippet

Sponsor: National Eye Institute (NEI) | Conditions: Anterior Uveitis | Phase 1 | Status: COMPLETED